7 unknown. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 7 |
| Phase 2 | 3 | Unknown 3 |
Follow Hearing Loss: new trials by email Literature Review of Hearing Loss trials Research Report on Hearing Loss
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BF844 Safety and Pharmacokinetic Study in Healthy Volunteers BF844 - Usher Syndrome Type 3 | Phase 1 | Unknown | EyeXCel Pty. Ltd. | 76 | 2024-09-09 | 2024-09-19 |
| Phase I Clinical Study of HY01 in Patients HY01 - Sudden Sensorineural Hearing Loss | Phase 1 | Unknown | Heyu (Suzhou) Pharmaceutical Technology Co., Ltd | 12 | 2021-06-23 | 2021-07-14 |
| Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity. N-Acetyl Cysteine - Ototoxic Hearing Loss | Phase 1 / Phase 2 | Unknown | Sunnybrook Health Sciences Centre | 80 | 2020-02-26 | 2023-09-06 |
| Effectiveness of P02 Digital Hearing Aids Hearing Aids Evaluation - Hearing Loss, Bilateral, Sensorineural Hearing Loss | Phase 1 / Phase 2 | Unknown | Khon Kaen University | 100 | 2012-10-01 | 2014-04-21 |
| Cochlear Implant PDA Based Research Platform ciPDA - Hearing Impaired | Phase 1 | Unknown | Philip Loizou | 60 | 2011-06-01 | 2012-06-15 |
| Hearing Impairment, Cognitive Therapy and Coping 8-session CBTcourse, 8 session cognitive behavioral therapy - Hearing Loss, Tinnitus | Phase 1 | Unknown | Oslo University Hospital | 180 | 2010-10-01 | 2013-06-14 |
| Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity Ringer's Lactate (0.03% Ciprofloxacin) - Hearing Loss | Phase 1 / Phase 2 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 20 | 2008-04-01 | 2010-04-22 |
Hearing Loss, Sensorineural (2) · Deafness (1) · Ear Diseases (1) · Escape Reaction (1) · Hearing Loss, Bilateral (1) · Hearing Loss, Sudden (1) · Mental Fatigue (1) · Ototoxicity (1) · Stress, Psychological (1) · Tinnitus (1) · Usher Syndromes (1)
Hearing Disorders (7) · Nervous System Diseases (7) · Neurologic Manifestations (7) · Otorhinolaryngologic Diseases (7) · Pathological Conditions, Signs and Symptoms (7) · Sensation Disorders (7) · Signs and Symptoms (7) · Ear Diseases (6) · Abnormalities, Multiple (1) · Behavior (1) · Behavior, Animal (1) · Behavioral Symptoms (1) · Blindness (1) · Chemically-Induced Disorders (1)
Acetylcysteine (1) · Ciprofloxacin (1) · Ringer's Lactate (1)
EyeXCel Pty. Ltd. (1) · Heyu (Suzhou) Pharmaceutical Technology Co., Ltd (1) · Khon Kaen University (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Oslo University Hospital (1) · Philip Loizou (1) · Sunnybrook Health Sciences Centre (1)
Canada (2) · Australia (1) · China (1) · Norway (1) · Thailand (1) · United States (1)
Benedict Tan, MBBS, FRACP (1) · Dong Pin, Doctor (1) · Egil W Martinsen, Prof. dr. med. (1) · Katharine C Williams, cand. psychol. (1) · Kwanchanok Yimtae, MD (1) · Philip Loizou, PhD (1) · Sam J Daniel, MD (1) · Trung N Le (1)